Rofecoxib
Jump to navigation
Jump to search
Rofecoxib is a cyclooxygenase 2 inhibitor drug used as an analgesic until it was voluntarily withdrawn from the market by Merck & Co in September, 2004 due to increased cardiovascular complications.[1]
References
- ↑ FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Recalls the Product (2004). Retrieved on 2007-11-18.